Value in Health

Evaluation of The Cost Effectiveness of Rifaximin-α In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium

http://dx.doi.org/10.1016/j.jval.2015.09.2216

Post author By Berni E R, Connolly M P, Conway P, Radwan A and Currie C J
Post date 1 November 2015

Berni E R, Connolly M, Conway P, Radwan A, Currie C J. 01 Nov 2015

Berni E R

Connolly M P

Conway P

Radwan A

Currie C J

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit